We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$21.4B
AUM Growth
+$4.44B
Cap. Flow
+$3.37B
Cap. Flow %
15.75%
Top 10 Hldgs %
23.93%
Holding
573
New
101
Increased
135
Reduced
75
Closed
168

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$235M
2
AMZN icon
Amazon
AMZN
+$216M
3
ATVI
Activision Blizzard
ATVI
+$191M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.2M
5
TSLA icon
Tesla
TSLA
+$76.8M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$114M
2
TGT icon
Target
TGT
+$112M
3
TMUS icon
T-Mobile US
TMUS
+$104M
4
C icon
Citigroup
C
+$99.3M
5
TWTR
Twitter, Inc.
TWTR
+$92.5M

Sector Composition

Rank Sector Weight
1 Technology 3.92%
2 Healthcare 3.45%
3 Consumer Discretionary 3.2%
4 Communication Services 2.88%
5 Utilities 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ON icon
276
ON Semiconductor
ON
$31.1B
$4.13M 0.02%
+66,168
New +$4.41M
ULTA icon
277
PUT
Ulta Beauty
ULTA
$23.6B
$3.94M 0.02%
+8,400
New +$3.62M
MBAC.U
278
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
$3.94M 0.02%
400,000
– –
TCRT icon
279
Alaunos Therapeutics
TCRT
$4.84M
$3.71M 0.02%
38,137
+10,000
+36% +$1.45M
BMEA icon
280
Biomea Fusion
BMEA
$92.1M
$3.62M 0.02%
429,400
– –
BX icon
281
PUT
Blackstone
BX
$113B
$3.57M 0.02%
+48,100
New +$4.15M
VMW
282
DELISTED
VMware, Inc
VMW
$3.46M 0.02%
+28,221
New +$3.25M
ARWR icon
283
Arrowhead Research
ARWR
$12.5B
$3.4M 0.02%
83,900
-195
-0.2% -$6.46K
URGN icon
284
UroGen Pharma
URGN
$2.26B
$3.38M 0.02%
380,600
– –
PFE icon
285
Pfizer
PFE
$154B
$3.31M 0.02%
+64,642
New +$3.1M
GS icon
286
CALL
Goldman Sachs
GS
$301B
$3.3M 0.02%
9,600
-218,800
-96% -$76.2M
AAL icon
287
PUT
American Airlines Group
AAL
$9.93B
$3.28M 0.02%
+258,100
New +$3.5M
AAL icon
288
CALL
American Airlines Group
AAL
$9.93B
$3.24M 0.02%
+254,900
New +$3.46M
GHRS icon
289
GH Research
GHRS
$2.03B
$3.05M 0.01%
314,930
– –
TSHA icon
290
Taysha Gene Therapies
TSHA
$1.83B
$2.92M 0.01%
1,292,600
+850,000
+192% +$1.72M
PSTX
291
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.89M 0.01%
545,700
– –
AUTL
292
Autolus Therapeutics
AUTL
$551M
$2.85M 0.01%
+1,500,000
New +$3.79M
CLFD icon
293
Clearfield
CLFD
$391M
$2.82M 0.01%
+30,000
New +$3.16M
LCTX icon
294
Lineage Cell Therapeutics
LCTX
$286M
$2.78M 0.01%
2,377,940
– –
ON icon
295
CALL
ON Semiconductor
ON
$31.1B
$2.72M 0.01%
+43,600
New +$2.91M
ZM icon
296
CALL
Zoom
ZM
$31.4B
$2.71M 0.01%
40,000
– –
TRDA icon
297
Entrada Therapeutics
TRDA
$271M
$2.69M 0.01%
199,066
– –
LXU icon
298
LSB Industries
LXU
$726M
$2.66M 0.01%
+200,000
New +$2.98M
ZVRA icon
299
Zevra Therapeutics
ZVRA
$682M
$2.62M 0.01%
571,200
– –
RAIN
300
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.51M 0.01%
313,200
– –
10 11
12
13 14

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Laurion Capital Management held 573 positions worth $21.4B, up 26% from $16.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $3.37B of net new capital in Q4 2022, opening 101 new positions and adding to 135 existing holdings. Its largest new stake was Tesla: 405,456 shares worth $49.9M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Target, an estimated $112M trimmed.

  • Laurion Capital Management's largest Q4 2022 buy was Tesla: 405,456 shares worth $49.9M.
  • Laurion Capital Management added most to Apple in Q4 2022, an estimated $235M increase.
  • Laurion Capital Management's biggest Q4 2022 reduction was Target, cutting an estimated $112M.
  • Laurion Capital Management fully exited JPMorgan Chase in Q4 2022, selling an estimated $114M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $21.4B portfolio in Q4 2022.
  • Laurion Capital Management opened 101 new positions and closed 168 in Q4 2022.
  • Laurion Capital Management's portfolio value rose 26% quarter-over-quarter to $21.4B.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.